12:00 AM
 | 
Apr 11, 2011
 |  BC Week In Review  |  Company News  |  Other News

KV Pharmaceutical genitourinary news

In an SEC filing dated April 4, investment fund Adage Capital Partners disclosed that it held about 3 million KV shares, or 6% of the company's outstanding shares. As of Dec. 31,...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >